Company Profiles

driven by the PitchBook Platform

Abrexa Pharmaceuticals

2011 FOUNDED
PRIVATE STATUS
Early Stage VC LATEST DEAL TYPE
$500K LATEST DEAL AMOUNT
1 INVESTORS
Description

Provider of drugs for the treatment of alzheimer disease. The company's drugs are used for the patients suffering from brain disorder, enabling patients to begin treatment more quickly and result in a higher likelihood of a successful treatment.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Primary Office
12481 High Bluff Drive
Suite 150
San Diego, CA 92130
United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Abrexa Pharmaceuticals’s full profile, request a free trial.

Abrexa Pharmaceuticals Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC 06-Sep-2011 $500K 00000 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Abrexa Pharmaceuticals Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Domain Associates Venture Capital Minority 000 0000 000000 0

Abrexa Pharmaceuticals Executive Team (2)

Name Title Board
Seat
Contact
Info
J. Earnest Villafranca Co-Chief Executive Officer & President
Eckard Weber MD Co-Chief Executive Officer, President, Board Member & Co-Founder

Abrexa Pharmaceuticals Board Members (2)

Name Representing Role Since Contact
Info
Eckard Weber MD Self Co-Chief Executive Officer, President, Board Member & Co-Founder 000 0000
Nicole Vitullo Domain Associates Board Member 000 0000
Questions or concerns about this profile? Reach out to website-support@pitchbook.com